Javascript must be enabled to continue!
Microarray analysis of lncRNA and mRNA expression profiles in patients with Legg-Calve-Perthes disease
View through CrossRef
BackgroundThe etiology and underlying pathogenic mechanisms of Legg-Calve-Perthes disease (LCPD) still remain unclear. A disruption of blood supply to the femoral head, producing ischemic necrosis, appears to be the critical pathological event. The lncRNAs play crucial roles in many biological processes and are dysregulated in various human diseases. However, its expression profiles and the potential regulatory roles in the development of LCPD have not been investigated.MethodsIn this study, differentially expressed lncRNA and mRNA of Legg-Calve-Perthes disease patients were profiled. Several GO terms and pathways that play important roles in the regulation of vascular structure, function or coagulation were selected for further analysis. The lncRNA -mRNA interacting networks in LCPD tissues were constructed to identify novel potential targets for further investigation.ResultsThe microarray analysis revealed that 149 lncRNAs and 37 mRNAs were up-regulated, and 64 lncRNAs and 250 mRNAs were down-regulated in LCPD tissues. After filtering, we finally found 14 mRNAs and constructed an mRNA-lncRNA interacting network. Through the analysis of the interaction network, we finally found 13 differentially expressed lncRNAs, which may be implicated in the pathogenesis of LCPD. These mRNAs/lncRNAs were further validated with qRT-PCR.ConclusionThe findings of this study established a co-expression network of disease-related lncRNAs and mRNAs which screened out from the concerned G.O. terms and Pathways, which may provide new sights for future studies on molecular mechanisms of LCPD.
Frontiers Media SA
Title: Microarray analysis of lncRNA and mRNA expression profiles in patients with Legg-Calve-Perthes disease
Description:
BackgroundThe etiology and underlying pathogenic mechanisms of Legg-Calve-Perthes disease (LCPD) still remain unclear.
A disruption of blood supply to the femoral head, producing ischemic necrosis, appears to be the critical pathological event.
The lncRNAs play crucial roles in many biological processes and are dysregulated in various human diseases.
However, its expression profiles and the potential regulatory roles in the development of LCPD have not been investigated.
MethodsIn this study, differentially expressed lncRNA and mRNA of Legg-Calve-Perthes disease patients were profiled.
Several GO terms and pathways that play important roles in the regulation of vascular structure, function or coagulation were selected for further analysis.
The lncRNA -mRNA interacting networks in LCPD tissues were constructed to identify novel potential targets for further investigation.
ResultsThe microarray analysis revealed that 149 lncRNAs and 37 mRNAs were up-regulated, and 64 lncRNAs and 250 mRNAs were down-regulated in LCPD tissues.
After filtering, we finally found 14 mRNAs and constructed an mRNA-lncRNA interacting network.
Through the analysis of the interaction network, we finally found 13 differentially expressed lncRNAs, which may be implicated in the pathogenesis of LCPD.
These mRNAs/lncRNAs were further validated with qRT-PCR.
ConclusionThe findings of this study established a co-expression network of disease-related lncRNAs and mRNAs which screened out from the concerned G.
O.
terms and Pathways, which may provide new sights for future studies on molecular mechanisms of LCPD.
Related Results
Is Legg-Calvé-Perthes Disease a Local Manifestation of a Systemic Condition?
Is Legg-Calvé-Perthes Disease a Local Manifestation of a Systemic Condition?
Background
Osteochondrosis includes numerous diseases that occur during rapid growth, characterized by disturbances of endochondral ossification. One example, Legg-Calv...
REHABILITASI MEDIK PADA PENYAKIT LEGG-CALVÉ-PERTHES
REHABILITASI MEDIK PADA PENYAKIT LEGG-CALVÉ-PERTHES
Abstract: In Legg-Calvé-Perthes disease there is an avascular necrosis condition of the femoral head with a clinical onset between the ages of 2-12 years old. The etiology of this...
Abstract IA3: Regulatory networks in onco-lncRNAomics: Cis-regulation and non-conservation
Abstract IA3: Regulatory networks in onco-lncRNAomics: Cis-regulation and non-conservation
Abstract
Global studies of the transcriptome reveal that approximately half of human transcriptional units (genes) encode solely non-protein-coding RNAs (ncRNAs), wh...
Tissue renin angiotensin system in IgA nephropathy
Tissue renin angiotensin system in IgA nephropathy
The inhibition of angiotensin II (AngII) by use of angiotensin converting enzyme (ACE) inhibitor or AngII receptor blocker is effective for prevention of the progression of renal d...
Identification of Long Non‐Coding RNA as Potential Biomarkers for the Diagnosis of Postmenopausal Osteoporosis
Identification of Long Non‐Coding RNA as Potential Biomarkers for the Diagnosis of Postmenopausal Osteoporosis
Objective: To explore the feasibility and clinical application value of differentially expressed lncRNA in human peripheral blood mononuclear cell (PBMC) as a potential biomarker f...
Abstract A08: A novel lncRNA RGMB-AS inhibit NSCLC metastasis via upregulating the expression of target gene RGMB
Abstract A08: A novel lncRNA RGMB-AS inhibit NSCLC metastasis via upregulating the expression of target gene RGMB
Abstract
Background: The relationships between long noncoding RNA (lncRNAs) and tumors have currently become one of the focuses on cancer studies. Our previous studi...
Developmental Hip Dysplasia Presenting as Bilateral Osteochondritis Dissecans Perthes-like Lesions Treated with Triple Pelvic Osteotomies: A Case Report
Developmental Hip Dysplasia Presenting as Bilateral Osteochondritis Dissecans Perthes-like Lesions Treated with Triple Pelvic Osteotomies: A Case Report
Introduction: Osteochondritis dissecans (OCD) of the femoral head accounts for approximately 2% of all OCD cases. Most of the OCD lesions affecting the femoral head are secondary t...
Long non-coding RNA (LncRNA) as a biomarker and therapeutic agent for cancer
Long non-coding RNA (LncRNA) as a biomarker and therapeutic agent for cancer
Long non-coding RNA (lncRNA) are transcripts of >200 nucleotides that do not translate into proteins. Once considered as a part of transcriptional noise, now with advanced genom...

